Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Ware

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Psychiatric Services (Washington, D.C.)|July 4, 2006
PRISM-E: comparison of integrated care and enhanced specialty referral in managing at-risk alcohol useDavid W Oslin, Susan Grantham, Eugenie Coakley, et al.
Journal of the American College of Cardiology|May 3, 2008
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, Derek P Chew, James W Hoekstra, et al.
Journal of the American Heart Association|December 11, 2025
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold-Standard Clinical Models in Multiethnic PopulationsMaddalena Ardissino, Kypros Nicolaides, Frances Conti-Ramsden, et al.
JACC. Clinical Electrophysiology|February 19, 2021
Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated CardiomyopathyGabriel Balaban, Brian P Halliday, Bradley Porter, et al.
European Journal of Heart Failure|September 30, 2024
Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remissionLeanne Cheng, Daniel Hammersley, Aaraby Ragavan, et al.
PLOS Digital Health|February 25, 2026
AI-ECG classification for Brugada syndrome: A study of machine learning techniques to optimise for limited datasetsKeenan Saleh, Raaif Hadadi, Yixiu Liang, et al.
Scientific Reports|July 28, 2018
Identification of an I<sub>Na</sub>-dependent and I<sub>to</sub>-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patientDongrui Ma, Zhenfeng Liu, Li Jun Loh, et al.
Circulation|October 2, 2024
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE RegistryNiccolò Maurizi, Panagiotis Antiochos, Anjali Owens, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDAlice Garrett, Chey Loveday, Laura King, et al.
Circulation|May 5, 2021
Evidence-Based Assessment of Genes in Dilated CardiomyopathyElizabeth Jordan, Laiken Peterson, Tomohiko Ai, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Psychiatric Services (Washington, D.C.)|July 4, 2006
PRISM-E: comparison of integrated care and enhanced specialty referral in managing at-risk alcohol useDavid W Oslin, Susan Grantham, Eugenie Coakley, et al.
Journal of the American College of Cardiology|May 3, 2008
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, Derek P Chew, James W Hoekstra, et al.
Journal of the American Heart Association|December 11, 2025
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold-Standard Clinical Models in Multiethnic PopulationsMaddalena Ardissino, Kypros Nicolaides, Frances Conti-Ramsden, et al.
JACC. Clinical Electrophysiology|February 19, 2021
Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated CardiomyopathyGabriel Balaban, Brian P Halliday, Bradley Porter, et al.
European Journal of Heart Failure|September 30, 2024
Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remissionLeanne Cheng, Daniel Hammersley, Aaraby Ragavan, et al.
PLOS Digital Health|February 25, 2026
AI-ECG classification for Brugada syndrome: A study of machine learning techniques to optimise for limited datasetsKeenan Saleh, Raaif Hadadi, Yixiu Liang, et al.
Scientific Reports|July 28, 2018
Identification of an I<sub>Na</sub>-dependent and I<sub>to</sub>-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patientDongrui Ma, Zhenfeng Liu, Li Jun Loh, et al.
Circulation|October 2, 2024
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE RegistryNiccolò Maurizi, Panagiotis Antiochos, Anjali Owens, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDAlice Garrett, Chey Loveday, Laura King, et al.
Circulation|May 5, 2021
Evidence-Based Assessment of Genes in Dilated CardiomyopathyElizabeth Jordan, Laiken Peterson, Tomohiko Ai, et al.
Pageof 4